Suchergebnisse - "SONG JAMES"

PubPharm (6)

1

A phase 1b, multicenter, open-label, dose-finding study of eribulin in combination with carboplatin in advanced solid tumors and non-small cell lung cancer

enthalten in: Cancer chemotherapy and pharmacology | 2019

von Goel, S. | Swami, U. | Kumar, K. | +6

2

Phase II, Multicenter, Single-Arm, Feasibility Study of Eribulin Combined With Capecitabine for Adjuvant Treatment in Estrogen Receptor-Positive, Early-Stage Breast Cancer

enthalten in: Clinical breast cancer | 2016

von Smith, J. | Vukelja, S. | Hoffman, A. | +5

3

Safety and tolerability of eribulin mesylate in patients with pretreated metastatic breast cancer

enthalten in: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists | 2015

von Goodin, S. | Barbour, S. | Song, J. | +2

4

"New" metastases are associated with a poorer prognosis than growth of pre-existing metastases in patients with metastatic breast cancer treated with chemotherapy

enthalten in: Breast cancer research : BCR | 2015

von Twelves, C. | Cortes, J. | Kaufman, P. | +8

5

Phase 2, multicenter, single-arm study of eribulin mesylate with trastuzumab as first-line therapy for locally recurrent or metastatic HER2-positive breast cancer

enthalten in: Clinical breast cancer | 2014

von Wilks, S. | Puhalla, S. | O'Shaughnessy, J. | +5

6

Phase 2 study of eribulin mesylate as first-line therapy for locally recurrent or metastatic human epidermal growth factor receptor 2-negative breast cancer

enthalten in: Breast cancer research and treatment | 2014

von McIntyre, K. | O'Shaughnessy, J. | Schwartzberg, L. | +5

ErratumIn: Breast Cancer Res Treat. 2014 Jul;146(2):329

1
[1]